Non-Monoaminergic Targets for the Development of Antidepressants: Focus on Neuropeptides

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|13|1|2-10

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.13, Iss.1, 2013-01, pp. : 2-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Targets for the Development of Novel Antidepressants: Future Perspectives

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 2, 2015-03 ,pp. : 270-281

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the Autonomic Nervous System and Neuropeptides in the Development of Obesity in Humans: Targets for Therapy?

By  

Current Pharmaceutical Design, Vol. 14, Iss. 18, 2008-06 ,pp. : 1815-1820

Bentham Science Publishers

Access to resources Recommend Favorite

New approaches to developing antidepressants by enhancing monoaminergic neurotransmission

By Bymaster Frank P   McNamara Robert K   Tran Pierre V  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 531-543

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptides as emerging targets in anorexia and cachexia

By Asakawa A.   Inui A.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 1, 2000-02 ,pp. : 73-87

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptides as Therapeutic Targets in Anxiety Disorders

By  

Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. : 5709-5727

Bentham Science Publishers

Access to resources Recommend Favorite